Cardiothoracic Surgery: Acute Coronary Syndrome (ACS)
Definitions
Definitions
- Acute Coronary Syndrome (ACS) – A Constellation of Clinical Symptoms Consistent with Acute Myocardial Ischemia
- Includes Myocardial Infarction (MI) & Unstable Angina (UA)
- Coronary Artery Disease (CAD) – Diseased/Damaged Coronary Blood Vessels
- Angina Pectoris – Severe Chest Pain Due to Inadequate Heart Blood Supply
- Myocardial Infarction (MI/Heart Attack) – Death of Myocardium Cells Due to Obstruction of Blood Flow
Types of Angina Pectoris
- Stable Angina – Brief Episodes Associated with Exercise or Stress & Relieved with Rest
- Unstable Angina (UA)
- Prolonged Angina at Rest (> 20 Minutes)
- New-Onset Severe Angina
- Worsening Angina (More Frequent, Severe or Longer Duration)
- Variant/Prinzmetal Angina – Angina Due to Coronary Artery Spasm
Types of Myocardial Infarction (MI)
- ST-Segment Elevation Myocardial Infarction (STEMI) – MI Associated with ST-Segment Elevation
- Indicates a Full-Thickness Injury
- Non-ST-Segment Elevation Myocardial Infarction (NSTEMI) – MI Not Associated with ST-Segment Elevation
- Indicates a Subendocardial (Not Full-Thickness) Injury
- Type 1 NSTEMI – Spontaneous from Atherothrombotic Plaque Rupture or Erosion
- Type 2 NSTEMI – Due to Oxygen Supply-Demand Imbalance
- Type 3 NSTEMI – Cardiac Death without Biomarker Samples or Detected at Autopsy
- Type 4 NSTEMI – Associated with Revascularization Procedures
- 4a: Related to Percutaneous Coronary Intervention (PCI) within 48 Hours
- 4b: Related to Stent Thrombosis
- 4c: Restenosis After Percutaneous Coronary Intervention (PCI)
- Type 5 NSTEMI – Related to CABG Procedure within 48 Hours
Acute Coronary Syndrome (ACS)
Basics
- Coronary Artery Disease is the Most Common Cause of Death in the United States
- 95% of Myocardial Ischemia is Due to Underlying Atherosclerotic CAD
- Most Atherosclerosis is Proximal
- Risk Factors for Increased Mortality:
- Cardiogenic Shock – Strongest Risk Factor
- Emergency Setting
- Increased Age
- Low Ejection Fraction
Presentation
- Chest Pain/Discomfort – Most Common Symptom
- Classic Description: Substernal Chest Tightness/Pressure with Radiation to Left Arm or Jaw
- Shortness of Breath
- Diaphoresis
- Weakness
- Anxiety
Complications of Myocardial Infarction (MI)
- Reinfarction
- Occurs Within 48 Hours
- Postinfarct Angina
- Mechanical Complications:
- Interventricular Septum Rupture
- Left Ventricular Free Wall Rupture
- Papillary Muscle Rupture
- Conduction Abnormality
- Left Ventricular Aneurysm
- Post-Cardiac Injury Syndrome (PCIS)
- Also Known As:
- Dressler’s Syndrome
- Post-Pericardiotomy Syndrome
- Post-Myocardial Infarction Syndrome
- Definition: Pericarditis from Injury to the Pericardium
- Develops Weeks-Months After Myocardial Infarction (MI)
- Presentation:
- Pericardial Friction Rub
- Fever
- Pleuritic Chest Pain
- Shortness of Breath
- Can Cause Pericardial Effusion
- EKG Findings: Diffuse ST-Segment Elevation
- Treatment: NSAIDs, Colchicine & Steroids
- Also Known As:
Diagnosis
Diagnosis of Myocardial Infarction (MI)
- Elevated Troponin with ≥ One Of:
- Symptoms of Myocardial Ischemia
- New Ischemic Changes on EKG
- Development of Pathologic Q Waves
- New Loss of Viable Myocardium or Regional Wall Motion Abnormality Consistent with Ischemic Etiology on Imaging
- Identification of a Coronary Thrombus by Angiography or Autopsy
- Coronary Angiogram is the Standard Tool for Describing Surgical Anatomy of CAD
Differentiation
- STEMI: Elevated Troponin with ST-Elevation on EKG
- NSTEMI: Elevated Troponin without ST-Elevation on EKG
- UA: Normal Troponin
EKG Changes
- ST-Segment Changes (Elevation or Depression)
- Left Bundle Branch Block (LBBB)
- T Wave Inversion
- Q Waves
- Lead Laterality:
- Anterior: V1-V4 (Indicates Left Anterior Descending (LAD) Artery Disease)
- Posterior: V1 & V2 (Indicates Right Coronary Artery or Left Circumflex Artery Disease)
- Lateral: I & aVL (Indicates Left Circumflex Artery Disease)
- Inferior: II, III & aVF (Indicates Right Coronary Artery Disease)
Cardiac Enzymes
- Troponin I
- Best Test for Detecting Acute MI
- Highest Sensitivity & Specificity
- Remains Elevated for 5-14 Days
- Generally Trended Every 3-6 Hours
- Creatine Kinase-MB (CK-MB)
- Remains Elevated for 2-3 Days
- Best for Detecting Recurrence
Treatment
Treatment
- Medical Managements:
- Oxygen Supplementation
- Antiplatelet Therapy (Aspirin or Clopidogrel (Plavix))
- Other NSAIDs Should Be Discontinued – Increased Risk of Cardiovascular Events
- Beta Blockers
- Contraindicated in Heart Failure, Heart Block or Cardiogenic Shock
- Statin Therapy
- Sublingual Nitroglycerin – Vasodilation to Relieve Chest Pain
- Contraindicated in Hypotension or Cardiogenic Shock
- Consider Morphine for Persistent Severe Pain
- Reperfusion
- Fibrinolysis
- Percutaneous Coronary Intervention (PCI) – Goal Door-to-Balloon Time < 90 Minutes
- Coronary Artery Bypass Graft (CABG)
Cardiogenic Shock
Coronary Artery Bypass Graft (CABG) Indications
- Left Main Disease > 50% Stenosis
- Triple-Vessel Disease > 70% Stenosis (Right Coronary Artery, Left Anterior Descending Artery & Circumflex Artery)
- Double-Vessel Disease with Proximal Left Anterior Descending (LAD) Artery Disease
- At Least One Vessel with Significant (> 70%) Stenosis with Unacceptable Angina Despite Medical Therapy
- May Also Consider Percutaneous Coronary Intervention (PCI)
- Survivors of Sudden Cardiac Death with Ischemia-Mediated Ventricular Tachycardia
- Emergency CABG:
- After Failed Percutaneous Coronary Intervention (PCI) with Ongoing Ischemia or Threatened Occlusion of Substantial Myocardium
- Cardiogenic Shock Due to Myocardial Infarction (MI)
- Undergoing Noncoronary Cardiac Surgery with Left Main Disease (> 50%) or Any Other CAD (> 70%)
Percutaneous Coronary Intervention (PCI)
- Radial Access Generally Preferred Over Femoral Access (Decreased Risk of Bleeding Complications)
- Stents:
- Drug-Eluting Stents (DES) – Generally Preferred
- Decreased Risk of Restenosis
- Bare Metal Stent (BMS)
- Drug-Eluting Stents (DES) – Generally Preferred
- Dual Antiplatelet Therapy (DAPT)
- Agents: Aspirin & Clopidogrel (Plavix)
- Duration of Therapy:
- Drug-Eluting Stents (DES) – One Year
- Bare Metal Stent (BMS) – One Month